Gainers
- Benitec Biopharma (NASDAQ:BNTC) shares increased by 9.8% to $0.35 during Tuesday's after-market session. The company's market cap stands at $9.0 million.
- TherapeuticsMD (NASDAQ:TXMD) stock rose 9.14% to $7.52. The company's market cap stands at $70.8 million.
- Aytu BioPharma (NASDAQ:AYTU) stock rose 7.89% to $0.2. Aytu BioPharma's trading volume hit 1.6 million shares by close, accounting for 129.8% of its average volume over the last 100 days. The market value of their outstanding shares is at $12.7 million. As per the news, the Q4 earnings report came out today.
- POINT Biopharma Global (NASDAQ:PNT) stock increased by 7.89% to $8.75. This security traded at a volume of 58.8K shares come close, making up 7.1% of its average volume over the last 100 days. The market value of their outstanding shares is at $910.2 million.
- TCR2 Therapeutics (NASDAQ:TCRR) shares rose 7.69% to $1.82. The company's market cap stands at $70.2 million.
- Outlook Therapeutics (NASDAQ:OTLK) shares rose 6.72% to $1.27. Trading volume for this security closed at 157.6K, accounting for 33.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $287.2 million.
Losers
- PhaseBio Pharmaceuticals (NASDAQ:PHAS) shares decreased by 14.5% to $0.65 during Tuesday's after-market session. The market value of their outstanding shares is at $32.4 million.
- Kiromic BioPharma (NASDAQ:KRBP) stock declined by 9.2% to $0.31. The company's market cap stands at $4.8 million.
- Evaxion Biotech (NASDAQ:EVAX) stock declined by 7.5% to $2.22. The company's market cap stands at $53.2 million.
- Aquestive Therapeutics (NASDAQ:AQST) shares decreased by 7.02% to $1.06. Today's trading volume for this security ended up closing at 6.7 million shares, which is 975.4 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $56.5 million.
- AnPac Bio-Medical Science (NASDAQ:ANPC) shares fell 6.26% to $0.14. The company's market cap stands at $5.5 million.
- Kala Pharmaceuticals (NASDAQ:KALA) shares fell 5.99% to $0.22. The company's market cap stands at $16.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!